KI-Beratung Beta

Produktbild: Microbiota-Gut-Brain Axis and CNS Disorders
- 13%

Microbiota-Gut-Brain Axis and CNS Disorders Recent Progress and Perspectives

13% sparen

137,99 € UVP 159,40 €

inkl. gesetzl. MwSt., Versandkostenfrei


Beschreibung

Microbiota-Gut-Brain Axis and CNS Disorders: Recent Progress and Perspectives on Human Disease summarizes the main findings on gut-brain axis in different types of CNS disorders, providing a complete overview of the field. The content helps unravel the complex interactions of the microbiota-gut-brain-axis...

Beschreibung

Microbiota-Gut-Brain Axis and CNS Disorders: Recent Progress and Perspectives on Human Disease summarizes the main findings on gut-brain axis in different types of CNS disorders, providing a complete overview of the field. The content helps unravel the complex interactions of the microbiota-gut-brain-axis in CNS disorders to pave a better understanding of microbiota-mediated pathogenesis, avenues for noninvasive prognosis, and therapeutic possibilities leveraging microbiota-gut-brain-axis modulations. Coverage includes the role of the microbiota-gut-brain axis and gut virome on human diseases including Alzheimer s Disease, Parkinson s Disease, Huntington s Disease, Depression and Anxiety, Autism Spectrum Disorder, Multiple Sclerosis, Stroke, and others.
This book will satisfy the urgent need for a broader view of the current associations between gut microbiota alterations and development of CNS disorders, including the use of novel therapeutic approaches for restoring the correct intestinal bacteria content. It is the perfect reference for translational and clinical gut and microbiome researchers tackling the challenges of delivering genes and drugs in a more targeted and efficient manner for the treatment of CNS disorders.

Portrait

Neeraj Mishra is Professor and Head of the Department of Pharmaceutics at the Amity Institute of Pharmacy, Amity University Madhya Pradesh, Gwalior, India. His academic work focuses on novel drug delivery systems, including localized, targeted, and controlled delivery approaches using nanocarrier and microparticle-based technologies. His research interests encompass therapies for cancer and neurodegenerative disorders, and he has extensive experience in teaching, research supervision, and scholarly publishing. He has also contributed to innovation in pharmaceutical sciences through intellectual property development and collaborative academic activities. Through his research and educational initiatives, he supports the advancement of drug delivery strategies and pharmaceutical research.

Anoop Kumar is Assistant Professor in the Department of Pharmacology at the Delhi Institute of Pharmaceutical Sciences and Research (DIPSAR), Delhi Pharmaceutical Sciences and Research University (DPSRU), Government of NCT of Delhi, India. He has held academic and research positions in pharmaceutical education, translational research, and the pharmaceutical industry. His professional activities include teaching, research, editorial service, ethics committee responsibilities, and engagement with professional organizations. His research interests include drug repurposing, meta-analysis of clinical trials, network pharmacology, pharmacoeconomics, pharmacovigilance, and experimental pharmacology. He has contributed to scientific publishing and research initiatives that support evidence-based approaches to drug discovery, development, and healthcare decision-making.

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

29.01.2025

Herausgeber Neeraj Mishra + weitere
Verlag Elsevier Science & Technology

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

29.01.2025

Herausgeber
Verlag Elsevier Science & Technology
Seitenzahl

514

Maße (L/B/H)

23,4/19,1/2,4 cm

Gewicht

1039 g

Sprache

Englisch

ISBN

978-0-443-21680-0

EU-Ansprechpartner

Elsevier B.V.
Radarweg 29
1043 NX Amsterdam
NL
productsafety@elsevier.com

Herstelleradresse

Elsevier Science & Technology
London Wall 125
EC2Y 5AS London
GB
tradeorders@elsevier.com

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)

Die Leseprobe wird geladen.
  • Produktbild: Microbiota-Gut-Brain Axis and CNS Disorders
  • 1. Introduction: An overview of Microbiota-Gut- Brain Axis
    2. Role of Microbiota-Gut- Brain Axis in Alzheimer disease and possible interventions
    3. Role of Microbiota Gut- Brain axis in Parkinson’s disease
    4. Role of Microbiota-Gut- Brain Axis in Huntington’s disease and possible interventions
    5. Role of Microbiota-Gut- Brain Axis in depression and anxiety
    6. Role of microbiome- Gut Brain axis in autism spectrum disorder (ASD)
    7. Role of Microbiota- Gut brain axis in autoimmunity and Multiple Sclerosis
    8. Role of Microbiome Gut- Brain axis in stress
    9. Role of Microbiota- Gut Brain Axis in epilepsy and possible interventions
    10. Role of Microbiota- Gut Brain Axis in migraine and possible interventions
    11. Role of Microbiota- Gut Brain Axis in stroke and possible interventions
    12. Role of Microbiota- Gut Brain Axis in brain infections and possible interventions
    13. Role of Microbiome Gut- Brain axis in brain disorders
    14. Role of GUT microbiota in neuropsychiatric and neurological disorders
    15. Role of Microbiota- Gut Brain Axis in Obesity on Cognitive Functions and Mood
    16. Role of Microbiota- Gut Brain Axis on Neurotransmitters modulation
    17. Role of gut virome and mycobiome in neurological disorders
    18. Role of nutraceuticals in neurological diseases
    19. Future prospective of Microbiome- Gut brain axis for treatment of CNS disorders